We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$547M
AUM Growth
-$7M
Cap. Flow
+$35.4M
Cap. Flow %
6.47%
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
AXGN icon
Axogen
AXGN
+$19.5M
2
GYRE icon
Gyre Therapeutics
GYRE
+$16M

Top Sells

Rank Stock Value
1
ACUR
Acura Pharmaceuticals
ACUR
+$61.2K

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABMD
1
DELISTED
Abiomed Inc
ABMD
$199M 36.46%
2,150,000
– –
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$137M 24.98%
4,592,047
– –
CORI
3
DELISTED
Corium International, Inc.
CORI
$87.5M 15.99%
9,353,304
– –
ENTL
4
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$68.7M 12.56%
3,813,197
– –
ELGX
5
DELISTED
Endologix Inc
ELGX
$21.2M 3.88%
125,747
– –
AXGN icon
6
Axogen
AXGN
$2.63B
$20M 3.66%
+4,861,111
New +$19.5M
GYRE icon
7
Gyre Therapeutics
GYRE
$703M
$5.66M 1.03%
+10,483
New +$16M
ACUR
8
DELISTED
Acura Pharmaceuticals
ACUR
$4.6M 0.84%
1,956,397
-18,000
-0.9% -$61.2K
MNOV icon
9
MediciNova
MNOV
$65.5M
$3.29M 0.6%
1,170,370
– –

Similar funds

TSM
Two Star Manager Miami Beach, Florida $254M AUM 3.61% 1-Year Est. Return
LI
LHM Inc Sandy, Utah $254M AUM 13.16% 1-Year Est. Return
LIA
LifePlan Investment Advisors Raleigh, North Carolina $254M AUM 17.26% 1-Year Est. Return
IGM
Incline Global Management New York $255M AUM 7.23% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
MWM
MorganRosel Wealth Management Highlands Ranch, Colorado $254M AUM 18.87% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return

Essex Woodlands Management's Q3 2015 Portfolio in Review

As of Q3 2015, Essex Woodlands Management held 9 positions worth $547M, down 1.3% from $554M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management deployed $35.4M of net new capital in Q3 2015, opening 2 new positions. Its largest new stake was Axogen: 4,861,111 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier.

On the sell side, the largest reduction was Acura Pharmaceuticals, an estimated $61.2K trimmed.

  • Essex Woodlands Management's largest Q3 2015 buy was Axogen: 4,861,111 shares worth $20M.
  • Essex Woodlands Management's biggest Q3 2015 reduction was Acura Pharmaceuticals, cutting an estimated $61.2K.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $547M portfolio in Q3 2015.
  • Essex Woodlands Management opened 2 new positions and closed 0 in Q3 2015.
  • Essex Woodlands Management's portfolio value fell 1.3% quarter-over-quarter to $547M.

Based on Essex Woodlands Management's 13F filing for Q3 2015, filed 16 Nov 2015.